Literature DB >> 24136793

The scarlet H.

David W Kimberlin1.   

Abstract

Keywords:  HSV; genital herpes; herpes simplex virus type 1; herpes simplex virus type 2; neonatal herpes

Mesh：

Substances：

Year:  2013        PMID： 24136793      PMCID： PMC3883169          DOI： 10.1093/infdis/jit459

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.

Authors:  W M Sullender; J L Miller; L L Yasukawa; J S Bradley; S B Black; A S Yeager; A M Arvin
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

4.  Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L M Frenkel; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

5.  Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L Corey; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S Weller; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

6.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

Review 7.  Neonatal herpes simplex infection.

Authors:  David W Kimberlin
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Authors:  Zane A Brown; Anna Wald; R Ashley Morrow; Stacy Selke; Judith Zeh; Lawrence Corey
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

9.  Natural history of genital herpes simplex virus type 1 infection.

Authors:  Rebecca Engelberg; David Carrell; Elizabeth Krantz; Lawrence Corey; Anna Wald
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

10.  Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.

Authors:  Craig M Roberts; John R Pfister; Scott J Spear
Journal:  Sex Transm Dis       Date:  2003-10       Impact factor: 2.830
View more
  3 in total

1.  Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009-2015.

Authors:  Sanjay Mahant; Matt Hall; Amanda C Schondelmeyer; Jay G Berry; David W Kimberlin; Samir S Shah
Journal:  Pediatrics       Date:  2019-04       Impact factor: 7.124

2.  Mother-to-Child Transmission of Herpes Simplex Virus.

Authors:  Scott H James; Jeanne S Sheffield; David W Kimberlin
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

3.  Characteristics of neonatal herpes simplex virus infections in Germany: results of a 2-year prospective nationwide surveillance study.

Authors:  André Kidszun; Anna Bruns; Daniel Schreiner; Susanne Tippmann; Julia Winter; Roman M Pokora; Michael S Urschitz; Eva Mildenberger
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-07-13       Impact factor: 5.747
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.